GENE ONLINE|News &
Meribel Pharma Solutions Launches as CDMO with Ten Manufacturing Sites Across Europe.
Meribel Pharma Solutions has entered the contract development and manufacturing organization (CDMO) market, establishing a presence in multiple European countries. The company’s launch follows acquisitions in France, Spain, and Sweden, resulting in a network of ten manufacturing sites. The new CDMO will concentrate on specialised drug development and production. The company’s formation through acquisitions across France, Spain and Sweden has provided the company with a network of ten manufacturing sites as it begins operations.
Newsflash | Powered by GeneOnline AI
Date: April 15, 2025
Related posts:
BIO International Convention Celebrating its 25th Anniversary in Boston
FDA Approves Pfizer/BioNTech’s COVID-19 Vaccine for 5- to 11-Year-Olds
QOL Medical’s Sucraid Single-Use Containers Approved For Patients With Sucrase Deficiency
Guide Aims to Strengthen Drug Patent Applications Through Effective Drafting
LATEST
The Latest Talk in Cancer Immunotherapy: A Brief Overview of Developments & Current Players in the Exosome Space
2025-04-23
Unlocking the Gut Code: Japan’s Pharmaceutical Sector Explores the Future of Microbiome Therapeutics
2025-04-23
Advancing Pharmaceutical Regulatory Cooperation in Asia: The Vision and Challenges of GMP Inspection Reliance
2025-04-23
Cross-Border Trust and Transparency: The New Landscape of Bridging the Regulatory Review in the Asia-Pacific
2025-04-23
